Clinical trials
Completed Phase 3 trials in Bangladesh
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
68 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 3 |
| 2002 | 2 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 4 |
| 2007 | 3 |
| 2008 | 2 |
| 2010 | 5 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 7 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 3 |
| 2019 | 1 |
| 2020 | 6 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 7 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 68 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| International Centre for Diarrhoeal Disease Research, Bangladesh | 15 |
| GlaxoSmithKline | 5 |
| The Hospital for Sick Children | 5 |
| Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 4 |
| Johns Hopkins Bloomberg School of Public Health | 4 |
| Centers for Disease Control and Prevention | 2 |
| NICHD Global Network for Women's and Children's Health | 2 |
| PATH | 2 |
| Serum Institute of India Pvt. Ltd. | 2 |
| Shakeela Ishrat | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Influenza, Human | 7 |
| Cholera | 5 |
| Pneumonia | 5 |
| COVID-19 | 4 |
| Infant Death | 4 |
| Poliomyelitis | 4 |
| Diarrhea | 3 |
| Leishmaniasis, Visceral | 3 |
| Malnutrition | 3 |
| Respiratory Tract Infections | 3 |
Trials
Showing 1 to 25 of 68. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.